Structure | Chemical Name | CAS | MF |
|
26S-PROTEASOME FRACTION, MAMMALIAN
|
|
|
|
SQI-ET SODIUM FORM
|
|
C38H52N4O7
|
|
S-PROTEIN HRP CONJUGATE
|
|
|
|
20S PROTEASOME
|
|
|
|
S-100 PROTEIN, BOVINE
|
|
|
|
S-PROTEIN AGAROSE
|
|
|
|
S-PROTEIN AP CONJUGATE
|
|
|
|
26S PROTEASOME SUBUNIT FRAGMENT ( C13-LEU)
|
|
C30H54N8O11
|
|
S-100 PROTEIN, HUMAN
|
|
|
|
20(S)-PROTOPANAXADIOL
|
|
|
|
S2 protein, equine infectious anemia virus
|
|
|
|
S10 protein, epizootic hemorrhagic disease virus 2
|
|
|
|
S10 protein, rice gall dwarf virus
|
144714-17-0
|
|
|
SPROUTS
|
|
|
|
sprouty-1 protein
|
|
|
|
sprouty 2 protein
|
|
|
|
sprouty protein
|
|
|
|
sprouty4 protein
|
|
|
|
Sproutnip 3E
|
|
|
|
SPROUT NIP 7A
|
|
|
|
Sproutnip 4A
|
|
|
|
SPROUTINHIBITORS
|
|
|
|
(S)-Proxyphylline
|
86540-95-6
|
|
|
Spr-2 protein
|
|
|
|
Spr18 protein
|
|
|
|
SPR3 protein
|
|
|
|
SPR28 protein
|
|
|
|
spr1 protein
|
|
|
|
SPRR2A protein
|
|
|
|
SPRR1a (Small Proline-Rich Repeat Protein 1A)
|
|
|
|
SPRR1a (Small Proline-Rich Repeat Protein 1A) (KLH)
|
|
|
|
SpSHR2 protein
|
|
|
|
spruce pathogen induced 1 protein
|
|
|
|
SPRUCE EXTRACT
|
|
|
|
Spruce, Picea abies, ext.
|
91770-69-3
|
|
|
SPRUCEWOODKRAFTLIGNIN
|
|
|
|
SPRUCETANNIN
|
|
|
|
SPRUCEDUST
|
|
|
|
SPRUCELEAF
|
|
|
|
SPRUCEWOODDUST
|
|
|
|
SPRUCERESIN
|
|
|
|
Spruceanol
|
72963-56-5
|
|
|
Spruce needles (trace elements)
|
|
|
|
SpRunt-1 protein
|
|
|
|
Spry-2 protein
|
|
|
|
S-59, psoralen
|
|
|
|
S-(p-tert-Butylphenyl)O-methyl=ethylphosphonodithioate
|
2984-66-9
|
|
|
[S,(+)]-2-(p-tert-Butylphenoxy)propionamide
|
|
|
|
SpSoxB1 protein
|
|
|
|
SQI-PR
|
|
C42H60N4O7
|
|
SR-95639A
|
|
|
|
SR-58079A
|
|
|
|
(SP-4-2)-[(7S,8S,17R,18R)-13-Acetyl-18-ethyl-5-(2-methoxy-2-oxoethyl)-2,8,12,17-tetramethyl-3-[[(2-sulfoethyl)amino]carbonyl]-21H,23H-porphine-7-propanoato(4-)-kN21,kN22,kN23,kN24]palladate(2-)
|
759457-82-4
|
C37H41N5O9PdS
|
|
(3S,4'R)-3aβ,4,5,6,6aβ,7,8,9,9aβ,9bα-Decahydro-4β-hydroxy-4'-methyl-6,9-bismethylenespiro[azuleno[4,5-b]furan-3(2H),2'-oxetan]-2-one
|
99305-07-4
|
|
|
(2S,12R)-1,2,3,4,4a,5,8,9,10,10aα,11,11aα-Dodecahydro-3,3,7-trimethyl-11-methylene-5aβ,8β-methano-5aH-cyclohepta[b]naphthalene-2,4α,4aβ,12-tetrol
|
38302-27-1
|
|
|
(3S,6R)-3aα,4,5,6,6aβ,7,8,9,9aβ,9bα-Decahydro-9-methylene-3-methylspiro[azuleno[4,5-b]furan-6,2'-oxiran]-2(3H)-one
|
|
|
|
SP (Substance P)
|
|
|
|
(9S,10R,4aβ,9aβ)-9β,10β-Epithio-4α-methoxy-1α-ethoxymethoxy-1,2,3,4,4a,9,9a,10-octahydroanthracene
|
|
|
|
(9S,10R,4aβ,9aβ)-9β,10β-Epithio-4α-methoxy-1α-[2-(dimethylamino)ethoxy]-1,2,3,4,4a,9,9a,10-octahydroanthracene
|
|
|
|
(9S,10R,4aβ,9aβ)-9β,10β-Epithio-4α-methoxy-1α-[(diethylamino)acetoxy]-1,4,4a,9,9a,10-hexahydroanthracene
|
|
|
|
(9S,10R,4aβ,9aβ)-9β,10β-Epithio-4α-methoxy-1α-[(piperidino)acetoxy]-1,4,4a,9,9a,10-hexahydroanthracene
|
|
|
|
(9S,10R,4aα,9aα)-9β,10β-Epithio-4β-methoxy-1β-[3-(dimethylamino)propoxy]-1,2,3,4,4a,9,9a,10-octahydroanthracene
|
|
|
|
S-100, Rabbit anti-
|
|
|
|
S-100, Rabbit anti-Bovine
|
|
|
|
S-100,RABBITANTI-HUMAN
|
|
|
|
(3S,13R)-1,2,3,4,4aα,5,11,11aα-Octahydro-2,2,5-trimethyl-3β,5β-ethano-10bH-pyrido[3,2-b]carbazole-10bβ,13-diol
|
66833-16-7
|
|
|
SP SUPPLEMENTS-LEU-URA
|
|
|
|
sp UAP2 protein
|
|
|
|
SP SUPPLEMENTS-LYS
|
|
|
|
SP SUPPLEMENTS
|
|
|
|
SPTM-2380
|
|
|
|
Sr(acac)2×tetraglyme
|
|
|
|
(2S)-4α-[[(1R)-2-Acetyl-1,2-dihydro-7,8-dihydroxyisoquinolin]-1β-ylmethyl]-3α-ethenyl-2β-(β-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylic acid methyl ester
|
|
|
|
[(2S,3R)-2-Acetyl-3-hydroxy-4-methylpentyl]phosphonic acid diisopropyl ester
|
|
|
|
(4S,5R)-5-Acetyl-3,5-dimethoxy-2-methyl-4-[(2S)-2-methylbutanoyl]-2-cyclopenten-1-one
|
|
|
|
[(2S,3R)-2-Acetyl-3-hydroxyhexyl]phosphonic acid diethyl ester
|
|
|
|
[(2S,3R)-2-Acetyl-3-hydroxy-4-methyl-4-pentenyl]phosphonic acid diisopropyl ester
|
|
|
|
[(2S,3R)-2-Acetyl-3-hydroxy-3-phenylpropyl]phosphonic acid diisopropyl ester
|
|
|
|
(3S,βR)-10α-Acetyloxy-β-bromo-3,4,4aα,5,6,6aβ,7,8,9,10,11,11a-dodecahydro-5α-hydroxy-3,11aα-dimethyl-7-methylene-9β-[(1-oxohexadecyl)oxy]-2H-cyclohepta[a]naphthalene-3α-ethanol
|
|
|
|
(3S)-2-[[(2R)-1-Acetyl-4β-propyloxypyrrolidin]-2β-ylcarbonyl]-N-methyl-1,2,3,4-tetrahydroisoquinoline-3α-carboxamide
|
|
|
|
[(2S,3R)-2-Acetyl-3-hydroxybutyl]phosphonic acid diisopropyl ester
|
|
|
|
(2S,3R)-2-Acetoxy-3-chlorobutyric acid methyl ester
|
|
|
|
(2S,3R)-4-Acetoxy-3-(trimethylsilyloxy)-2-cyclohexylbutanenitrile
|
|
|
|
(αS,βR)-α-Acetoxy-β-methyl-1H-indole-3-propanoic acid methyl ester
|
|
|
|
(3S,4R)-3-Acetoxy-4,5-epithiopentanenitrile
|
|
|
|
(4S,6R)-7β-Acetoxy-4α-(benzoyloxy)-5α-methyltricyclo[4.3.0.01,5]nonan-8-one
|
|
|
|
(2S)-4α-[[(1R)-2-Acetyl-1,2,3,4-tetrahydro-7,8-dihydroxyisoquinolin]-1β-ylmethyl]-3α-ethenyl-2β-(β-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylic acid methyl ester
|
|
|
|
(13β,14α,17S,20R)-11α-(Acetyloxy)-7α,17,21-trihydroxy-4,8-dimethyl-1-oxo-24-nor-16,17-seco-5α-chol-3-ene-16,23-dioic acid 16,7:23,17-dilactone
|
80458-50-0
|
|
|
(20S,22R)-22-Acetoxy-3β,14,25-trihydroxy-5β-cholest-7-en-6-one
|
|
|
|
(20S,24R)-11α-Acetoxy-20,24-epoxydammarane-3β,25-diol
|
|
|
|
(5S,11R)-12α-Acetoxy-5-methyl-5,6,11,12-tetrahydrodibenzo[a,e]cycloocten-5,11-imine
|
|
|
|
(2S)-4α-[[(1R)-2-Acetyl-1,2,3,4-tetrahydro-6-methoxy-7-hydroxyisoquinolin]-1β-ylmethyl]-3α-ethenyl-2β-(β-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylic acid methyl ester
|
|
|
|
(2S,3R)-4-Acetoxy-3-(trimethylsilyloxy)-2-isopropylbutanenitrile
|
|
|
|
(3S)-2-[[(2R)-1-Acetyl-4β-methoxypyrrolidin]-2β-ylcarbonyl]-N-methyl-1,2,3,4-tetrahydroisoquinoline-3α-carboxamide
|
|
|
|
(3S,4R)-4-Acetyl-3,5,5-trimethylcyclohexene
|
|
|
|
(2S,3R)-1-Acetoxy-3-iodohexan-2-ol
|
|
|
|
(2β,12S,19R)-4β-(Acetyloxy)-6,7-didehydro-3β-hydroxy-16-methoxy-1-methylaspidospermidine-3α-carboxylic acid methyl ester
|
|
|
|
(1S,4R)-9-Acetyl-1β,4β-ethano-1,4,4a,9a-tetrahydro-9H-carbazole
|
|
|
|
(βS,γR)-4-[[3-(4-Acetyl-3-hydroxy-2-propylphenoxy)propyl]thio]-γ-hydroxy-β-methylbenzenebutanoic acid sodium salt
|
|
|
|
(5S,19R)-17β-Acetoxy-19-methoxy-19,5-(epoxymethano)-5β-androstan-3-one
|
|
|